These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 26837238)

  • 21. Age-dependent effects of milrinone and levosimendan on ventricular function and haemodynamics in newborn and mature pigs.
    Hyldebrandt JA; Larsen SH; Schmidt MR; Hjortdal VE; Ravn HB
    Cardiol Young; 2011 Oct; 21(5):518-27. PubMed ID: 21733205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Effect of Levosimendan and Milrinone in Cardiac Surgery Patients With Pulmonary Hypertension and Left Ventricular Dysfunction.
    Mishra A; Kumar B; Dutta V; Arya VK; Mishra AK
    J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):639-46. PubMed ID: 27321790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of a myofilament calcium sensitizer on left ventricular systolic and diastolic function in rats with volume overload heart failure.
    Wilson K; Guggilam A; West TA; Zhang X; Trask AJ; Cismowski MJ; de Tombe P; Sadayappan S; Lucchesi PA
    Am J Physiol Heart Circ Physiol; 2014 Dec; 307(11):H1605-17. PubMed ID: 25260618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levosimendan restores the positive force-frequency relation in heart failure.
    Masutani S; Cheng HJ; Tachibana H; Little WC; Cheng CP
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H488-96. PubMed ID: 21572004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.
    Pagel PS; Harkin CP; Hettrick DA; Warltier DC
    J Pharmacol Exp Ther; 1995 Oct; 275(1):127-35. PubMed ID: 7562540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of temperature on the positive inotropic effect of levosimendan, dobutamine and milrinone.
    Rieg AD; Schroth SC; Grottke O; Hein M; Ackermann D; Rossaint R; Schälte G
    Eur J Anaesthesiol; 2009 Nov; 26(11):946-53. PubMed ID: 19687740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan.
    Haikala H; Kaheinen P; Levijoki J; Lindén IB
    Cardiovasc Res; 1997 Jun; 34(3):536-46. PubMed ID: 9231037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of levosimendan on myocardial infarct size and hemodynamics in a closed-chest porcine ischemia-reperfusion model.
    Busk M; Maeng M; Kristensen J; Berg JS; Mortensen UM; Nielsen TT; Nielsen-Kudsk JE
    Cardiovasc Drugs Ther; 2006 Oct; 20(5):335-42. PubMed ID: 17122904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
    De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
    Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inotropic and lusitropic effects of levosimendan and milrinone assessed by strain echocardiography-A randomised trial.
    Fredholm M; Jörgensen K; Houltz E; Ricksten SE
    Acta Anaesthesiol Scand; 2018 Oct; 62(9):1246-1254. PubMed ID: 29926912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of programmed forms of cell death by intracoronary levosimendan during regional myocardial ischemia in anesthetized pigs.
    Grossini E; Caimmi PP; Platini F; Molinari C; Uberti F; Cattaneo M; Valente G; Mary DA; Vacca G; Tessitore L
    Cardiovasc Drugs Ther; 2010 Feb; 24(1):5-15. PubMed ID: 20162343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New positive inotropic agents in the treatment of left ventricular dysfunction.
    De Luca L; Proietti P; Palombaro GL; Battagliese A; Celotto A; Bucciarelli Ducci C; Fedele F
    Ital Heart J; 2004 Jun; 5 Suppl 6():63S-67S. PubMed ID: 15185917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of levosimendan on balance between ATP production and consumption in isolated perfused guinea-pig heart before ischemia or after reperfusion.
    Eriksson O; Pollesello P; Haikala H
    J Cardiovasc Pharmacol; 2004 Sep; 44(3):316-21. PubMed ID: 15475828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic treatment of heart failure due to ventricular dysfunction by myocardial stunning: potential role of levosimendan.
    García González MJ; Domínguez Rodríguez A
    Am J Cardiovasc Drugs; 2006; 6(2):69-75. PubMed ID: 16555860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure.
    Oner E; Erturk M; Birant A; Kurtar Mansıroglu A; Akturk IF; Karakurt H; Yalcin AA; Uzun F; Somuncu MU; Yildirim A
    Cardiol J; 2015; 22(1):87-93. PubMed ID: 24846511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of levosimendan on left ventricular relaxation and early filling at maintained preload and afterload conditions after aortic valve replacement for aortic stenosis.
    Jörgensen K; Bech-Hanssen O; Houltz E; Ricksten SE
    Circulation; 2008 Feb; 117(8):1075-81. PubMed ID: 18268152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of levosimendan and milrinone on regional myocardial ischemia/reperfusion-induced arrhythmias in dogs.
    Papp JG; Pollesello P; Varró AF; Végh AS
    J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):129-35. PubMed ID: 16891290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate.
    Lechner E; Moosbauer W; Pinter M; Mair R; Tulzer G
    Pediatr Crit Care Med; 2007 Jan; 8(1):61-3. PubMed ID: 17149153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetaminophen and myocardial stunning after transient ischemia in rabbit hearts.
    Hale SL; Kloner RA
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10(2):121-9. PubMed ID: 15965563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations.
    Stehr SN; Christ T; Rasche B; Rasche S; Wettwer E; Deussen A; Ravens U; Koch T; Hübler M
    Anesth Analg; 2007 Sep; 105(3):641-7. PubMed ID: 17717217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.